Chiesi, Arbor in US$ 2 bn gene therapy deal; Lilly to invest over US$ 1 bn in India; FDA okays Boehringer’s rare lung disease drug
In news this week, Italy’s Chiesi Group announced a deal worth up to US$ 2 billion with US-based Arbor Biotechnologies to...
Impressions : 3976
Six CAR-T therapies to carry boxed warning for secondary cancer; Sanofi buys Inhibrx for about US$ 2.2 billion
The US Food and Drug Administration (FDA) has mandated “black box” warnings on six major CAR-T cancer therapies ove...
Impressions : 2734

